Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Virtual Advisory Committees Are Coming: US FDA Panels Will Be Smaller, More Focused

Executive Summary

Planning for virtual advisory committees is underway; any applications with upcoming PDUFA deadlines with meetings still on the calendar are prime candidates, OND Director Peter Stein says.

You may also be interested in...



US FDA May Publish Pre-Recorded Presentations Before Virtual Advisory Committee Meetings

The move is intended to streamline virtual advisory committee meetings, FDA official says.

Going Virtual: GSK’s Multiple Myeloma Drug Belantamab Tapped For US FDA Online AdComm In July

Announcement of the 14 July Oncologic Drugs Advisory Committee meeting follows a successful, two-day trial run of the virtual format by the oncology pediatric subcommittee that featured a mix of prerecorded and live sponsor presentations and strict adherence to a call/response approach to ensure orderly conduct.

US FDA May Make Pre-Recorded Virtual Adcom Presentations Available Before Meeting

The move is intended to streamline virtual advisory committee meetings, FDA official says.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS142031

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel